Press Releases
Chiome Bioscience Selects ProBioGen for GlymaxX® Antibody Manufacturing Program
read more Chiome Bioscience Selects ProBioGen for GlymaxX® Antibody Manufacturing Program
ProBioGen in Biosimilar Deal with Bio Farma Indonesia
read more ProBioGen in Biosimilar Deal with Bio Farma Indonesia
Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development
read more Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development